Can I Take 5-HTP with Praluent (Alirocumab)?
Clinical review of 5-HTP and Praluent (alirocumab) together: interaction risk, serotonin concerns, dose-separation guidance, and monitoring for patients on PCSK9 inhibitors.
Read clinical reviewTopic Hub
17 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 17 of 17 clinical reviews.
Clinical review of 5-HTP and Praluent (alirocumab) together: interaction risk, serotonin concerns, dose-separation guidance, and monitoring for patients on PCSK9 inhibitors.
Read clinical reviewClinical review of taking alpha-lipoic acid with Praluent (alirocumab). Covers interaction mechanisms, dose-separation windows, blood sugar monitoring, thyroid considerations, and what to do if you already take both.
Read clinical reviewA physician-reviewed guide to the ashwagandha and alirocumab interaction: mechanisms, evidence, monitoring parameters, and what to tell your cardiologist before combining them.
Read clinical reviewEvidence-based review of caffeine and alirocumab (Praluent) interactions, covering pharmacokinetic and pharmacodynamic data, cardiovascular monitoring, and practical dosing guidance.
Read clinical reviewEvidence-based guide on combining calcium supplements with Praluent (alirocumab). Covers pharmacokinetic interactions, dose-separation windows, monitoring, and clinical recommendations.
Read clinical reviewA clinician-reviewed guide to taking creatine while on Praluent (alirocumab): pharmacokinetic safety, the creatinine lab artifact, monitoring protocols, and what to tell your prescriber.
Read clinical reviewA physician-reviewed guide to combining folate supplements with Praluent (alirocumab), covering pharmacokinetic safety, MTHFR considerations, homocysteine monitoring, and practical dosing advice.
Read clinical reviewA physician-reviewed guide on ginseng and Praluent (alirocumab) interactions, covering mechanism, safety, monitoring, and what to do if you take both.
Read clinical reviewA clinician-reviewed guide to combining glutathione supplements with alirocumab (Praluent), covering pharmacokinetics, interaction evidence, dosing timing, and monitoring protocols.
Read clinical reviewEvidence-based guide on taking glycine supplements with Praluent (alirocumab). Covers interaction risk, pharmacokinetic data, dose-separation, monitoring, and clinical guidance.
Read clinical reviewEvidence-based guide on combining melatonin with Praluent (alirocumab). Covers interaction risk, pharmacokinetic and pharmacodynamic profiles, dose-separation guidance, monitoring, and clinical recommendations.
Read clinical reviewEvidence-based guide on combining omega-3 fatty acids (EPA/DHA) with Praluent (alirocumab). Covers interaction mechanisms, safety data, dosing guidance, and monitoring recommendations.
Read clinical reviewA clinician-reviewed guide to the resveratrol, alirocumab interaction: pharmacokinetics, safety, monitoring, and practical dosing advice for patients on Praluent.
Read clinical reviewA clinician-reviewed guide to the rhodiola and Praluent (alirocumab) interaction, covering pharmacokinetics, pharmacodynamics, serotonergic concerns, monitoring, and what to do if you are already taking both.
Read clinical reviewEvidence-based guide on taking vitamin B6 with Praluent (alirocumab). Covers interaction risk, dosing, monitoring, and clinical recommendations for safe co-administration.
Read clinical reviewEvidence-based guide on combining vitamin D supplements with Praluent (alirocumab). Covers interaction risk, monitoring, dosing, and what to tell your prescriber.
Read clinical reviewA clinician-reviewed guide on taking zinc supplements alongside Praluent (alirocumab). Learn about interaction mechanisms, copper balance, monitoring, and safe use guidance backed by primary literature.
Read clinical review